Dr Emil Marcher-Rorsted
Senior Research Scientist, Medicinal Chemistry
Emil is a Senior Research Scientist at Pangea Bio.
As co-founder of Lophora ApS, a Copenhagen based biotech company focusing on small-molecule NCEs targeting the 5-HT2A receptor, Emil was responsible for the initial synthesis of lead compound LPH-5 for treatment-resistant depression. He now brings to the team his expertise on the structure activity relationship of psychedelics and medicinal chemistry.
Emil holds a Bachelor, Master's and PhD in Medicinal Chemistry from the University of Copenhagen.
